Jame Abraham highlights the importance of time management for patients undergoing scalp cooling.
Colleen O’Leary, associate director for nursing education, The Ohio State University James Cancer Hospital, discusses the vital role nurses play in guiding the treatment of their patients with cancer.
Nicole Makris, BA, Emory University, discusses the findings that analyzed the HPV vaccination habits of women who have sex with women versus women who have sex with men.
Serena Wong, MD, medical oncologist, Stacy Goldstein Breast Cancer Center, Rutgers Cancer Institute of New Jersey, discusses ways to ease the symptoms of chemobrain.
Eileen Eisenhower, RN, BSN, CRNI, OCN, discusses the improvements to the CTCA-Eastern infusion room since they've added an emergency supplies box to handle hypersensitivity reactions.
The acceptance of next-generation sequencing (NGS) platforms and cell-free DNA (cfDNA) have enabled oncologists to more specifically target genetic mutations in the treatment of patients with non–small cell lung cancer (NSCLC), according to Benjamin P. Levy, MD.
Initial therapy with isatuximab plus VRd followed by its addition to Rd maintenance therapy led to significantly improved MRD negativity and PFS in transplant-ineligible multiple myeloma.
Patients who are diagnosed with cancer have cancer, cancer does not have them; they reflect what it means to be strong, a perfect picture of tenacity.
Gynecologic cancers present some of the most dangerous cancer-related threats to women, here's how to help patients understand what to look out for and the realities of their treatment.
Norman (Carl) Swart, PhD nursing student, Case Western Reserve University, defines palliative care and discusses challenges that nurses face.
Although ET significantly reduces the risk of HRpositive/ HER2- negative early breast cancer, the cumulative risk of distant recurrence has remained steady for decades.
Kevin Hughes, MD, breast surgeon at Massachusetts General Hospital, discusses misconceptions regarding dense breast tissue and risk for breast cancer.
Kathi Mooney, PhD, RN, FAAN, Louis S. Peery and Janet B. Peery Presidential Endowed Chair in Nursing, College Of Nursing, University of Utah, Co-Leader Cancer Control and Population Sciences, Huntsman Cancer Institute, discusses using an automated remote monitoring system to improve patients' side effects following chemotherapy treatment.
Managing immune-related adverse events is different from managing the effects of chemotherapy.
Leslie Schover, PhD, clinical psychologist and professor of Behavioral Science at the University of Texas MD Anderson Cancer Center, discusses the psychological elements of sexual dysfunction after cancer.
Blake A. Morrison, PharmD, vice president, Medical and Scientific Affairs, Multiple Myeloma Research Foundation, discusses adverse events associated with new agents to treat patients with multiple myeloma.
Julia Whiteker Describes the ONS Breast Care SIG Online Community
Barbara Daly, PhD, RN, FAAN, and Helen Foley, MSN, AOCNS®, offer highlights of their institution's oncology and palliative care program, which successfully prepares graduates to assume advanced practice roles in these important areas.
In fall of 2009, Smilow Cancer Hospital at Yale-New Haven opened a new, state-of-theart, 15-story, clinical facility with the latest advances in diagnostic, therapeutic, and surveillance procedures.
You are the world’s leading authority on your life and work. When mapping a plan for working through treatment, it’s important to marry your expertise with that of various members of your healthcare team.
G. Thomas Budd, MD, medical oncologist, Taussig Cancer Center at Cleveland Clinic, discusses genomic profiling for targeted therapies.
The anti-vaccination movement is causing outbreaks around the world, and may be even more dangerous for patients with cancer.
Sandra Ruland, RN, OCN, says she has to strike a delicate balance when talking to patients about how they use the internet to research their cancer.
Change is the one word that describes an immediate result of a cancer diagnosis. A patient’s world can be turned upside down, and they could end up facing obstacles including dietary changes, role changes within their family, and even changes in their activities of daily living.
At the 3rd annual School of Nursing Oncology (SONO) meeting, we got the chance to sit down with Madelaine Kuiper RN, MSN, and talk about what adverse events come with immune therapy for patients with breast cancer.
Oncology nurses’ intimate knowledge of their patients’ situations can enable them to match patients' needs to the appropriate resources.
Lisa Butterfield discusses what nurses should know when treating patients receiving immunotherapies.